Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2011-01-18
2011-01-18
Shiao, Rei-tsang (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C514S102000
Reexamination Certificate
active
07871992
ABSTRACT:
The present invention describes organophosphorus compounds of general formula (I)their preparation and their uses in the activation of gamma/delta T-cells, in the screening of GcpE and LytB enzyme inhibitors and in the prophylaxis and treatment of diseases in humans and animals.
REFERENCES:
patent: 5639653 (1997-06-01), Bloom et al.
patent: 5902793 (1999-05-01), Bloom et al.
patent: 6534050 (2003-03-01), Tanaka et al.
patent: 6624151 (2003-09-01), Belmant et al.
patent: 6660723 (2003-12-01), Belmant et al.
patent: 7399756 (2008-07-01), Jomaa et al.
patent: 2334711 (2000-12-01), None
patent: 2444955 (2003-10-01), None
patent: 11718 (2005-01-01), None
patent: WO 95/20673 (1995-08-01), None
patent: WO 00/00182 (2000-01-01), None
patent: WO 00 30653 (2000-06-01), None
patent: WO 00 59916 (2000-10-01), None
patent: WO 01/22816 (2001-04-01), None
patent: WO 01/94561 (2001-12-01), None
patent: WO 02/12478 (2002-02-01), None
patent: WO 02/083720 (2002-10-01), None
patent: WO 02/095011 (2002-11-01), None
patent: WO 03/038072 (2003-05-01), None
Belmant, C. et al. “3-Formyl-1-butyl pyrophosphate a novel mycobacterial metabolite-activating human gamma delta T cells”J. Biol. Chem, 1999, pp. 32079-32084, vol. 274, No. 45.
Takagi, M. et al. “Studies on the nomevalonate pathway: Formation of 2-C-methyl-Derythritol 2,4-cyclodiphosphate from 2-phospho-4(cytidine 5'-diphospho)-2-C-methyl-Derythritol” Tetrahedron Letters, 2000, pp. 3395-3398, vol. 41.
Tanaka, Y. et al. “Natural and synthetic non-peptide antigens recognized by human gamma delta T cells”Nature, May 11, 1995, pp. 155-158, vol. 375, No. 6527.
McClard, R.W. et al. “Novel phosphonylphosphinyl (P-C-P-C-) analogues of biochemically interesting diphosphates. Syntheses and properties of P-C-P-C-, analogues of isopentenyl diphosphate and dimethylallyl diphosphate”J. Am. Chem. Soc., 1987, pp. 5544-5545, vol. 109.
Jacob, L. et al. “On the influence of phosphoric ester groups in geranyldiphosphate biosynthesis”Bull. Soc. Chim. de France, 1990, pp. 719-733, vol. 127, No. 6.
Sireci, G. et al. “Differential activation of human gamma delta cells by nonpeptide phosphoantigens”Eur. J. Immunol., 2001, pp. 1628-1635, vol. 31.
Belmant, C. et al. “A chemical basis for selective recognition of nonpeptide antigens by human delta T cells,” FasebJ., Sep. 2000, pp. 1669-1670, vol. 14.
Hintz, M. et al. “Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human gamma delta T cells inEscherichia coli” Febs Lett., 2001, pp. 317-322, vol. 509.
Feurle, J. et al. “Echericheria coliproduces phosphoantigens activating human gamma delta T cells”J. Biol. Chem., Jan. 4, 2002, pp. 148-154, vol. 277, No. 1.
Espinosa, E. “Synaptic transfer by human gamma delta T cells stimulated with soluble or cellular antigens”J. Immunol., 2002, pp. 6336-6343, vol. 168.
Gao, W. et al. “(E)-4-hydroxy-3-methylbut-2-enyl diphosphate: An intermediate in the formation of terpenoids in plant Chromoplasts”Angew. Chem Int Ed., 2002, pp. 2604-2607, vol. 41, No. 14.
Fox, D.T. et al. “Synthesis of (E)-4-hydroxydimethylallyl diphosphate. An intermediate in the methyl erythritol phosphate branch of the isoprenoid pathway”J. Org. Chem., 2002, pp. 5009-5010, vol. 67, No. 14.
O'Brien, R.S. et al. “Depletion of a yσ T cell subset can increase host resistance to a bacterial infection”J. Immunol., 2000, pp. 6472-6479, vol. 165.
Schwender, J. “Die mevalonat-unabhängige isoprenoid-biosynthese und deren verbreitung in pflanzen”Dissertation, Universität Karlsruhe(Th) Nov. 10, 1999, pp. I-X and 1-168.
Santini, D. et al. “The antineoplastic role of bisphosphonates: from basic research to clinical evidence”Ann. Oncol., 2003, pp. 1468-1476, vol. 14.
Espinosa, E. et al. “Chemical synthesis and biological activity of bromohydrin pyrophosphate, a potent stimulator of human yσ T cells”J. Biol. Chem., May 25, 2001, pp. 18337-18344, vol. 276, No. 21.
Brondino, C. et al. “Synthesis of new phosphonic derivatives with fluorinated chains”J. Fluorine Chem., 1996, pp. 193-200, vol. 76.
Kunzmann, V. et al. “Stimulation of yσ T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma”Blood, Jul. 15, 2000, pp. 384-392, vol. 96, No. 2.
Valentijn, A.R.P.M. et al. “An expeditious synthesis of pyrophosphate analogues of farnesyl pyrophosphate using the phosphonylating agent methyl methylphosphonomorpholidate”Synlett, Sep. 1991, pp. 663-664.
Beytia, E.D. et al. “Biochemistry of polyisoprenoid biosynthesis”Annu. Rev. Biochem., 1976, pp. 113-142, vol. 45.
Rohmer, M. “The discovery of a mevalonate-independent pathway for isoprenoid biosynthesis in bacteria, algae and higher plants”Nat. Prod. Rep., 1999, pp. 565-574, vol. 16.
Jomaa, H. et al. “Vγ9/Vσ2 T cell activation induced by bacterial low molecular mass compounds depends on the 1-deoxy-D-xylulose 5-phosphate pathway of isoprenoid biosynthesis”FEMS Immunol. and Med. Microbiol., 1999, pp. 371-378, vol. 25.
Ward, J.L. et al. “Synthesis of (2E)-4-hydroxy-3-methylbut-2-enyl diphosphate, a key intermediate in the biosynthesis of isoprenoids”J. Chem. Soc., Perkin Trans. 1, 2002, pp. 710-712.
Seemann, M. et al. “Isoprenoid biosynthesis inEscherichia colivia the methylerythritol phosphate pathway: enzymatic conversion of methylerythritol cyclodiphosphate into a phosphorylated derivative of (E)-2-methylbut-2-en3-1,4-diol”Tetrahedron Lett., 2002, pp. 1413-1415, vol. 43.
Woodside, A.B. et al. “Trisammonium geranyl diphosphate”Org. Synth., 1988, pp. 211-219, vol. 66.
Sato, K. et al. “A new synthesis of α-santalol”Bull. Chem. Soc. Jpn., 1976, pp. 3351-3352, vol. 49, No. 11.
Hiroi, K. et al. “Palladium-catalyzed intramolecular metallo-ene reactions using allylic sulfones as enophiles”Chem. Pharm. Bull., 1994, pp. 786-791, vol. 42, No. 4.
Lensky, S. et al. “Use of Cyclic Phosphonic Acid Esters for Treatment of Brain Function Disorders and Depression”,CAS, 1999, 130:191901.
Brown, R.J. et al. “Isopentenyl pyrophosphate isomerase and/or prenyl transferaase inhibitors for therapeutic use”,CAS, 1997, 128:30414.
Belmant, C. et al. “Monoesters of methylenediphosphonic acids and salts selectively inhibiting Tγ9δ2 lymphocytes”,CAS, 2000, 133:276336.
Sciammas, R. et al. “TCRγσ cells and viruses”Microbes and Infection, 1999, pp. 203-212.
Espinosa, E. et al. “Y2K+1 state-of-the-art on non-peptide phosphoantigens, a novel category of immunostimulatory molecules”Microbes and Infection, 2001, pp. 645-654.
Fournie, J. J. et al. “Stimulation of γσT cells by phosphoantigens” 66thForum in Immunology, May 9, 1996, pp. 338-347.
Altincicek Boran
Eberl Mathias
Hintz Martin
Jomaa Hassan
Kollas Ann-Kristin
Bioagency AG
Saliwanchik Lloyd & Saliwanchik
Shiao Rei-tsang
LandOfFree
Organophosphorous compounds for the activation of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Organophosphorous compounds for the activation of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Organophosphorous compounds for the activation of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2691415